- Marketwired•yesterdayFluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting
FluoroPharma Medical Inc. announced today that data from its Phase II clinical trial for CardioPET were presented at the 21st Annual Meeting of the American Society of Nuclear Cardiology on September 24th, ...
- Marketwired•3 months ago
FluoroPharma Medical, Inc. today announced that the company will conduct a conference call with the investment community, scheduled at 4:30 p.m. EDT on Wednesday, June 22, 2016. The objectives of the call ...
- Marketwired•4 months ago
FluoroPharma Medical Inc. announced today that it has entered into a nonbinding letter of intent with Ground Fluor Pharmaceuticals, Inc. to acquire GFP.The transaction is conditioned on the close of sufficient ...
FluoroPharma Medical, Inc. (FPMI)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.67|
|Avg Vol (3m)||11,432|
|Dividend & Yield||N/A (N/A)|